MedTrace Logo

FLUENCY® PLUS in the Treatment of Peripheral Artery Disease

NCT04765566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 146

Last updated 2022-04-29

No results posted yet for this study

Summary

This is a retrospective, multi-center study to assess the safety and performance by proactively reviewing pre-existing medical records and imaging of patients who had previous placement of FLUENCY® PLUS Vascular Stent Graft in iliac artery vessel(s) between January 2010 and March 2020.

Conditions

  • Vascular Diseases, Peripheral

Interventions

DEVICE

Endovascular revascularization of peripheral arteries

Endovascular revascularization of peripheral arteries involves placement of a self-expanding Nitinol Stent encapsulated with ePTFE in diseased vessel segments

Sponsors & Collaborators

  • Cromsource

    collaborator INDUSTRY

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Grzegorz Halena, Prof. · Medical University of Gdansk

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-05
Primary Completion
2021-10-31
Completion
2022-02-28

Countries

  • Germany
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04765566 on ClinicalTrials.gov